Kuala Lumpur, December 5, 2024 – Takeda Malaysia has signed an MoU with managed care organization MiCare and leading insurers (Great Eastern Life Malaysia, Tokio Marine Life Malaysia, MCIS Life, Hong Leong Assurance, and Syarikat Takaful Malaysia Keluarga Berhad) to enhance dengue prevention efforts. This collaboration aims to benefit up to 1.7 million policy/certificate holders by increasing access to dengue vaccination and integrated prevention strategies.
Comprehensive Prevention Strategy:
• Raising awareness of dengue risks.
• Promoting vaccination alongside mosquito control measures to reduce dengue cases and hospitalizations.
Economic Impact:
• Dengue imposes a significant financial burden on Malaysia, costing approximately RM447 million annually.
• Vaccination could save RM4.3 billion over three decades.
• Expand access to dengue prevention resources.
• Empower communities to adopt integrated strategies, improving national health resilience.
4. Partners’ Statements:
• Dr. Lynette Moey (Takeda) emphasized the importance of partnerships in providing vaccination access.
• Moses Hee (MiCare) highlighted the role of vaccination in reducing dengue’s social and economic burden.
For more details, policyholders can contact their insurers or visit knowdengue.my for dengue prevention information.
Read more Business News
In 2026, we expect Malaysia’s economy will grow at +4.2%, underpinned by continued expansion in domestic…
Tambadana, a Malaysian financing company, enhances customer loyalty through engaging seasonal campaigns, promoting financial literacy…
PNB appoints Rizal Rickman Ramli as new President & Group CEO, succeeding Dato’ Abdul Rahman…
AMD unveiled MRC to strengthen AI networking. The protocol ensures GPUs stay synchronized under real‑world…
Frontken posts RM38.9m profit, driven by Malaysia O&G surge and Taiwan semicon demand; TP raised…
KLCI’s breakout above its symmetrical triangle formation signals further upside towards 1,777 as market sentiment…
This website uses cookies.